🔗 Permalink

Inventor profile of:

Jens Hoffmann

City:

Muhlenbeck

Country:

Germany

Published Applications:

14

Last publication date:

2012-06-21

Top Assignees for applications by Jens Hoffmann

The entities that hold a legal rights for patent applications filed by inventor Hoffmann Jens:

SCHERING AG 2 Berlin, Germany
Bayer Schering Pharma Aktiengesellschaft 2 Berlin, Germany
Bayer Schering Pharma AG 1 Berlin, Germany
Bayer Intellectual Property GmbH 1 Monheim, Germany
Sterix Limited 1 Berkshire, United Kingdom
Bayer Pharma Aktiengesellschaft 1 Berlin, Germany

Recent patent applications by Hoffmann Jens

Jens Hoffmann from Muhlenbeck, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2012-06-21

US20120157421A1

Human necessities

17Beta-Alkyl-17Alpha-oxy-estratrienes

#2 | 2011-09-27

US10217165

Antitumor-active 2-alkoxyestradiol sulfamates

#3 | 2011-01-27

US20110021493A1

Chemistry; metallurgy

Substituted tricyclic compounds and methods of use thereof

#4 | 2009-10-20

US10728098

Effector conjugates, methods for their preparation and their pharmaceutical use

#5 | 2009-06-25

US20090163450A1

Human necessities

COMBINATIONS COMPRISING A PROSTAGLANDIN AND USES THEREOF

#6 | 2009-03-19

US20090076098A1

METHODS, KITS, AND COMPOUNDS FOR DETERMINING RESPONSIVENESS TO TREATMENT OF A PATHOLOGICAL DISORDER BY EPOTHILONES

#7 | 2009-01-29

US20090029954A1

Human necessities

PROGESTERONE-RECEPTOR ANTAGONIST FOR USE IN BRCA ALONE OR AS COMBINATION WITH ANTIESTROGEN

#8 | 2008-10-30

US20080268041A1

Human necessities

COMBINATION OF PROGESTERONE-RECEPTOR ANTAGONIST TOGETHER WITH NONE-STEROIDAL ANTIESTROGEN FOR USE IN BRCA MEDIATED DISEASES

#9 | 2008-10-23

US20080261933A1

Human necessities

COMBINATION OF PROGESTERONE-RECEPTOR ANTAGONIST TOGETHER WITH A LUTEIN-HORMONE-RELEASING HORMONE AGONIST AND ANTAGONIST FOR USE IN BRCA MEDIATED DISEASES

#10 | 2008-10-23

US20080261929A1

Human necessities

COMBINATION OF PROGESTERONE-RECEPTOR ANTAGONIST TOGETHER WITH AN AROMATASE INHIBITOR FOR USE IN BRCA MEDIATED DISEASES

#11 | 2006-12-07

US20060276413A1

Chemistry; metallurgy

New effector conjugates, methods for their preparation and their pharmaceutical use

#12 | 2006-10-24

US9979939

6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations

#13 | 2006-03-28

US10305418

17α-ALKYL-17β-OXY-ESTRATRIENES AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION, USE OF THE 17α-ALKYL-17β-OXY-ESTRATRIENES FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS AS WELL AS PHARMACEUTICAL PREPARATIONS

#14 | 2006-01-12

US20060009436A1

Chemistry; metallurgy

17α-alkyl-17β-oxy-estratrienes and intermediate products for their production, use of the 17α-alkyl-17β-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations

InventorID:

3198046 ⎘